Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 5,111,000 | 4,798,000 | 4,768,000 | 4,807,000 | 5,033,000 |
| Cost of Goods | 1,414,000 | 1,280,000 | 1,277,000 | 1,306,000 | 1,433,000 |
| Gross Profit | 3,697,000 | 3,518,000 | 3,491,000 | 3,501,000 | 3,600,000 |
| Operating Expenses | 2,104,000 | 1,937,000 | 1,960,000 | 2,135,000 | 2,348,000 |
| Operating Income | 1,593,000 | 1,581,000 | 1,531,000 | 1,366,000 | 1,252,000 |
| Other Income | -180,000 | 33,000 | 61,000 | 86,000 | 68,000 |
| Pre-tax Income | 1,413,000 | 1,614,000 | 1,592,000 | 1,452,000 | 1,320,000 |
| Income Tax | 571,000 | 312,000 | 324,000 | 351,000 | 188,000 |
| Net Income Continuous | 842,000 | 1,302,000 | 1,268,000 | 1,101,000 | 1,132,000 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 7,221,000 |
| Minority Interests | 359,000 | 353,000 | 341,000 | 358,000 | 328,000 |
| Net Income | $483,000 | $949,000 | $927,000 | $743,000 | $8,025,000 |
| EPS Basic Total Ops | 0.28 | 0.55 | 0.54 | 0.43 | 4.05 |
| EPS Basic Continuous Ops | 0.49 | 0.76 | 0.74 | 0.64 | 0.37 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 3.61 |
| EPS Diluted Total Ops | 0.28 | 0.55 | 0.53 | 0.43 | 4.05 |
| EPS Diluted Continuous Ops | 0.49 | 0.75 | 0.73 | 0.64 | 0.38 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 3.60 |
| EBITDA(a) | $1,654,000 | $1,749,000 | $1,722,000 | $1,553,000 | $1,434,000 |